Ekso Bionics Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Chronoscale

05/05/2025 22:02

Ekso Bionics Holdings Inc EKSO.OQ reported a quarterly adjusted loss of 12 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -20 cents.  The mean expectation of two analysts for the quarter was for a loss of 11 cents per share.

Revenue fell 10.1% to $3.38 million from a year ago; analysts expected $4.62 million.

Ekso Bionics Holdings Inc's reported EPS for the quarter was a loss of 12 cents​.

The company reported a quarterly loss of $2.89 million.

Ekso Bionics Holdings Inc shares had risen by 19.9% this quarter and lost 20.8% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 37.5% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Ekso Bionics Holdings Inc is $5.00

This summary was machine generated from LSEG data May 5 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.11
-0.12
Missed
Dec. 31 2024
-0.08
-0.14
Missed
Sep. 30 2024
-0.10
-0.10
Met
Jun. 30 2024
-0.13
-0.13
Met